Citadel Advisors’s DTRT Health Acquisition Corp. Class A Common Stock DTRT Stock Holding History

Citadel Advisors’s Portfolio DTRT Stock Details DTRT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-625,175	Closed	-$6.36M	–	15773
2022 Q3	$6.36M	Buy	625,175 +75	+0%	+$758	﹤0.01%	3479
2022 Q2	$6.3M	Sell	625,100 -972,411	-61%	-$9.76M	﹤0.01%	3385
2022 Q1	$16M	Sell	1,597,511 -2,852	-0.2%	-$28.5K	﹤0.01%	2270
2021 Q4	$16M	Buy	+1,600,363	New	+$16M	﹤0.01%	2319

Other funds holding DTRT

Meteora Capital Boca Raton, Florida $1.36B AUM 21.19% 1-Year Est. Return

OCAM

Owl Creek Asset Management New York $1.38B AUM 59.67% 1-Year Est. Return

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

CAC

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return

Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return

Citadel Advisors's DTRT Position: Q4 2022 in Review

Citadel Advisors sold out of DTRT Health Acquisition Corp. Class A Common Stock (DTRT) in Q4 2022, closing a stake of 625,175 shares — an estimated $6.36M sold.

Citadel Advisors first reported a position in DTRT in Q4 2021 and held it in 4 quarters. The position peaked at $16M in Q1 2022. 17 funds tracked by Wall St. Rank hold DTRT as of Q4 2022.

Citadel Advisors reported no remaining DTRT Health Acquisition Corp. Class A Common Stock position as of Q4 2022 after selling out during the quarter.
Citadel Advisors sold 625,175 DTRT Health Acquisition Corp. Class A Common Stock shares in Q4 2022, an estimated $6.36M.
Citadel Advisors first reported a position in DTRT Health Acquisition Corp. Class A Common Stock in Q4 2021 and held it in 4 quarters.
Citadel Advisors's DTRT Health Acquisition Corp. Class A Common Stock position peaked at $16M in Q1 2022.
17 funds tracked by Wall St. Rank held DTRT Health Acquisition Corp. Class A Common Stock as of Q4 2022.

Based on Citadel Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.